The Korean film Sugar, released nationwide on January 21, portrays the everyday reality of families raising children with Type 1 Diabetes (T1D), bringing attention to the emotional and social challenges that often remain unseen.
Based on a true story, the film is inspired by Kim Mi-young, head of the Type 1 Diabetes Patients Association, whose experiences as a mother of a child with T1D are reflected through the character “Mira.” Sugar depicts the constant vigilance, quiet anxiety, and daily decisions that define ordinary life for many families.
Beyond individual experiences, the film also addresses broader societal prejudice and misunderstandings surrounding Type 1 Diabetes. It highlights how families often face misjudgment, lack of awareness, and emotional burdens that extend beyond medical management.
Image source: Official trailer of <Sugar>
In Korea, such misunderstandings once extended into regulation. For many years, access to continuous glucose monitoring (CGM) technologies was restricted, forcing families to rely on limited alternatives. Through continued advocacy efforts led by patient groups and caregivers, this environment has evolved, leading to the legal approval of CGM in Korea.
Today, i-SENS is proud to be the first Korean company to successfully develop and launch a continuous glucose monitoring system in the domestic market. This milestone represents not only technological advancement, but also growing societal recognition and support for people living with diabetes.
i-SENS remains committed to improving the lives of patients and families like those portrayed in Sugar, and to supporting a future where individuals with Type 1 Diabetes can live healthier, more confident lives free from prejudice.
Sugar is currently screening in theaters nationwide. i-SENS encourages continued interest and dialogue to help broaden understanding and awareness of Type 1 Diabetes.
